Telemedicin Counselling for Medical Abortion
Status
Conditions
Treatments
Details and patient eligibility
About
The guidance on Safe abortion technology by the World Health Organization (WHO 2012) suggests the evaluation of internet provision and telemedicine, as further alternative service delivery channels of safe abortion, as a subject for future research (WHO 2012) Our studies have shown that telemedicine and provision of medical abortion through wow is safe, acceptable and with outcomes similar to medical abortion provided traditionally following face-to-face counselling. Furthermore, recently home self-assessment of the abortion outcome through a low sensitivity U-hCg test was shown to be highly acceptable to women. To evaluate whether counselling through telemedicine is non-inferior to face-to face counselling a RCT will be conducted including women who chose medical abortion up to 63 days of gestation with home administration of misoprostol and self assessment of the outcome. The results of this study could be of major importance to increase access to safe and acceptable abortion services.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- requesting termination of pregnancy by means of mifepristone followed by home administration of misoprostol at < /=63 days of gestation, no contraindication to medical abortion and self administration of misoprostol at home, and who have given their informed consent
Exclusion criteria
- women who do not want home administration of misoprostol, women who are unable to communicate in Swedish, or English, and women with symptoms and signs of ectopic pregnancy.
Trial design
Primary purpose
Allocation
Interventional model
Masking
1,598 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Kristina Gemzell Danielsson, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal